N Kamada Selected Research

2,3- dihydro- 5- hydroxy- 2,2- dipentyl- 4,6- di- tert- butylbenzofuran

1/2001

Macrophage scavenger receptor (SR-A I/II) deficiency reduced diet-induced atherosclerosis in C57BL/6J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Kamada Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2001 - 01/2000
4	Neoplasms (Cancer) 01/2019 - 05/2000
3	Leukemia 12/2001 - 10/2000
2	Inflammation (Inflammations) 01/2019 - 04/2011
2	Neoplasm Metastasis (Metastasis) 10/2005 - 02/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Colitis 04/2011
1	Erythema elevatum diutinum 09/2008
1	Extramammary Paget Disease (Paget Disease, Extramammary) 10/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2004
1	Pathologic Complete Response 12/2001
1	Melanoma (Melanoma, Malignant) 02/2001
1	Genetic Translocation (Chromosomal Translocation) 02/2001
1	Starvation 02/2001
1	Ataxia (Dyssynergia) 01/2001
1	Vitamin E Deficiency 01/2001
1	Atherosclerosis 01/2001
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2000
1	Chromosome Inversion (Chromosomal Inversion) 07/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2000
1	Lymphoma (Lymphomas) 05/2000
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2000
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2000
1	Castleman Disease (Castleman's Disease) 01/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2000
1	Primary Effusion Lymphoma 01/2000

Drug/Important Bio-Agent (IBA)

2	Interleukin-12 (IL 12)IBA 04/2011 - 02/2001
2	Topoisomerase II InhibitorsIBA 11/2001 - 02/2001
2	Etoposide (VP 16)FDA LinkGeneric 11/2001 - 02/2001
2	CytokinesIBA 02/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 01/2001 - 07/2000
2	DNA (Deoxyribonucleic Acid)IBA 05/2000 - 01/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	AluminumIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 04/2011
1	Immunoglobulin A (IgA)IBA 09/2008
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2008
1	AndrogensIBA 10/2005
1	Laminin (Merosin)IBA 01/2004
1	Keratins (Keratin)IBA 01/2004
1	Interleukin-4 (Interleukin 4)IBA 02/2001
1	Interleukin-2 (IL2)IBA 02/2001
1	Aminophylline (Carine)FDA LinkGeneric 02/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2001
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 02/2001
1	alpha-Tocopherol FDA Link 01/2001
1	alpha-tocopherol transfer proteinIBA 01/2001
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2001
1	2,3- dihydro- 5- hydroxy- 2,2- dipentyl- 4,6- di- tert- butylbenzofuranIBA 01/2001
1	AntioxidantsIBA 01/2001
1	quinone (benzoquinone)IBA 10/2000
1	NAD (NADH)IBA 10/2000
1	Oxidoreductases (Dehydrogenase)IBA 10/2000
1	Glutathione (Reduced Glutathione)IBA 10/2000
1	EnzymesIBA 10/2000
1	Cytochrome P-450 CYP3AIBA 10/2000
1	nuclear pore complex protein 98IBA 09/2000
1	AgarIBA 05/2000
1	Codon (Codons)IBA 05/2000
1	Complementary DNA (cDNA)IBA 05/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2000
1	Biological ProductsIBA 01/2000

Therapy/Procedure

2	Therapeutics 01/2018 - 10/2000
2	Drug Therapy (Chemotherapy) 12/2001 - 11/2001
1	Radiotherapy 12/2009
1	Stem Cell Transplantation 12/2001